Duitse aandelen « Terug naar discussie overzicht

quote:

N audio schreef op 18 april 2024 09:38:

Dezelfde patentstrijd mbt Xarelto is overigens wel recent gewonnen in Nederland, Duitsland en Zweden.
Sinds afgelopen Woensdag is het wel regelmatig topdrukte geweest bij het uitleenloket voor aandelen.
Firma list en bedrog druk bezig met het lenen van de stukken.

quote:

N audio schreef op 24 april 2024 12:32:

Shortvolume ratio is nu hoog bij Bayer.
Met andere woorden: shortsellers zijn proactief bezig de koers continue te drukken.
Blijkbaar is het interessant om de koers actief aan de ketting te leggen?
Wanneer Bayer dus niet op mag lopen, kan je de vraag stellen waarom dit zo belangrijk is voor shortende partijen?

Wellicht is het aandeel interessanter dan we vermoeden? Anders probeer je de boel toch niet constant uit te roken, en aan de boom blijven schudden?
Afgelopen week regelmatig shortvolume ratio van rond de 80%. Bron Fintel.
Natuurlijk is dat bij één broker, maar ik denk dan toch dat de "heren" dit spelletje elders ook spelen.

Ik ben toch benieuwd.

quote:

4finance schreef op 24 april 2024 13:27:

[...]

Feit is natuurlijk wel als er ook maar een klein beetje positief nieuws komt. vliegt het aandeel omhoog.
Dan gaat er flink gecoverd worden in een korte tijd en kan de koers "tijdelijk"fors oplopen.
In die zin kan je zeggen; BAYER is een buy.

quote:

N audio schreef op 24 april 2024 14:04:

[...]

Ik blijf het maar lastig vinden. Wat andere poster hierboven schreef, ja hij heeft een punt.
Maar dat is enkel van toepassing wanneer er de komende jaren helemaal niets meer uit de koker van Bayer zou vloeien. En dat vind ik maar moeilijk om aan te nemen.
Ik heb een overzichtelijke positie hier, die ik enkel ga uitbreiden wanneer dat de moeite zou lonen.

quote:

LL schreef op 25 april 2024 09:22:

UPDATE 1-Judge slashes $857 mln Monsanto verdict to $438 mln in PCBs case

By Clark Mindock

April 24 (Reuters) - A Washington state judge has nearly halved a $857 million verdict against Bayer’s Monsanto in a lawsuit over chemical pollution at a Seattle-area school, ruling that the company should pay $438 million instead.

Monsanto spinoff Pharmacia was found liable by a jury in December for selling polychlorinated biphenyls (PCBs) used in the Sky Valley Education Center in Monroe, Washington, that were not safe and did not contain adequate warnings.

The verdict included $73 million in compensatory damages and $784 million in punitive damages for the plaintiffs, seven former students and parent volunteers at the school who said PCBs caused them neurological, endocrine system and other health issues.

King County Superior Court Judge Jim Rogers let the $73 million component stand in a ruling on Tuesday, but he reduced punitive damages to five times that amount, or $365 million, and shaved another $1.5 million from the judgment to account for a related settlement.

Monsanto had argued in January that the original award was unconstitutionally excessive. The U.S. Supreme Court has said that punitive damages should generally not be more than nine times compensatory damages.

A spokesperson for Monsanto, which agreed to defend Pharmacia in PCBs litigation, said in a statement Wednesday that the company is pleased with the decision but plans to appeal the jury's findings. The spokesperson said the award is still too high and that the plaintiffs were not exposed to unsafe levels of PCBs.

Spokespeople for the plaintiffs declined to comment on Wednesday.

Employees, students and others have claimed in numerous lawsuits against Monsanto that exposure to PCBs at the Sky Valley center gave them cancer, thyroid conditions and other health problems.

PCBs are chemicals once widely used to insulate electrical equipment and found in other common products like carbon copy paper, caulking, floor finish and paint. The U.S. government outlawed the chemicals in 1979 after discovering links to cancer.

The December verdict marked the latest trial loss for Monsanto, which already faced roughly $870 million in verdicts from alleged PCBs exposure at the Sky Valley center in other cases. Monsanto is appealing those verdicts.

The company has said it stopped producing PCBs in 1977. It has also said the school had been warned repeatedly by government officials that light fixtures containing the chemicals needed to be retrofitted, but that those warnings were ignored.

The case is Bard v. Pharmacia, King County Superior Court in Washington, No. 21-2-14305-5.

For the Bard plaintiffs: Henry Jones, Richard Friedman, Sean Gamble and James Hertz of Friedman Rubin

For Monsanto: Jean-Claude Andre, Elizabeth Blackwell, Kenneth Marshall and Sarah Hartley of Bryan Cave Leighton Paisner

(Reporting by Clark Mindock)

quote:

LL schreef op 2 mei 2024 09:04:

Bayer's Monsanto wins reversal of $185 million PCBs verdict in Washington court

May 1(Reuters) - A Washington state appeals court on Wednesday overturned a $185 million verdict against Bayer's BAYGn.DE Monsanto unit over chemical contamination at a Seattle-area school, marking the second big legal win for the company in as many weeks.

Monsanto spinoff Pharmacia, which sold now-banned chemicals called polychlorinated biphenyls, was found liable in 2021. Three teachers claimed they suffered brain damage from PCBs that leaked from light fixtures at the Sky Valley Education Center in Monroe, Washington.

On Wednesday, the state Court of Appeals agreed with Bayer that the lower court improperly applied the laws of Missouri, where Monsanto is based, which allowed the claims to be filed decades after the company stopped producing PCBs in 1977.

The U.S. government outlawed the chemicals in 1979 after discovering links to cancer.

Bayer argued Washington law limits liability if exposure occurs outside a product's useful lifespan, which generally means 12 years.

The case will go back to the lower court to determine whether a new trial is warranted. Plaintiffs' attorney Richard Friedman said in a statement they will retry the case if necessary but hope the state Supreme Court "simply reinstates the verdict" on appeal.

Bayer faces about 200 similar claims from the school, where people allege PCBs caused cancer, thyroid conditions and other health problems.

Juries in some of those cases have awarded more than $1.7 billion in compensatory and punitive damages. But another Washington judge nearly halved an $857 million verdict against the company last week in a small group of those claims.

The company has denied responsibility for the alleged harms and says the school failed to heed repeated warnings to replace the lights. It is appealing the verdicts.

Monsanto said Wednesday's ruling, which also found the lower court wrongfully allowed punitive damages on some claims and erroneously allowed certain expert testimony, is "significant," and many or all of the other trials from the school may have had the same errors. The company said it will evaluate how to proceed in those cases and others yet to be tried.

PCBs were once widely used to insulate electrical equipment and found in other common products like caulking and paint.

(Reporting by Clark Mindock, Editing by Alexia Garamfalvi and Cynthia Osterman)